Article Data

  • Views 201
  • Dowloads 138

This is a correction to: European Journal of Gynaecological Oncology. 2024; 45(2): 16-23. https://doi.org/10.22514/ejgo.2024.023

Corrections

Open Access

Correction: Predictive value of multimodal ultrasound imaging and BCL-2 expression levels in the outcome of neoadjuvant chemotherapy for breast cancer

  • Xueqin Hou1
  • Junxi Gao1
  • Yibin Liu1
  • Wei Han1
  • Zhiming Li1
  • Tao Song1,*,

1Department of Abdominal Ultrasound Diagnosis, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Key Laboratory of Ultrasound Medicine, 830054 Urumqi, Xinjiang Uygur Autonomous Region, China

DOI: 10.22514/ejgo.2026.046 Vol.47,Issue 3,October 2026 pp.144-145

Published: 15 October 2026

*Corresponding Author(s): Tao Song E-mail: tsong8987@163.com

PDF (252.29 kB) View Full-text

Cite and Share

Xueqin Hou, Junxi Gao, Yibin Liu, Wei Han, Zhiming Li, Tao Song. Correction: Predictive value of multimodal ultrasound imaging and BCL-2 expression levels in the outcome of neoadjuvant chemotherapy for breast cancer. European Journal of Gynaecological Oncology. 2026; 47(3): 144-145. doi: 10.22514/ejgo.2026.046

References

[1] Hou XQ, Gao JX, Liu YB, Han W, Li ZM, Song T. Predictive value of multimodal ultrasound imaging and BCL-2 expression levels in the outcome of neoadjuvant chemotherapy for breast cancer. European Journal of Gynaecological Oncology. 2024; 45: 16–23.

Submission Turnaround Time

Top